Journal of the American Society of Hypertension
Volume 1, Issue 3 , Pages 164-168 , May 2007

Molecular mechanism of juxtaglomerular cell hyperplasia: a unifying hypothesis

  • Kenichi Matsushita, MD, PhD

      Affiliations

    • Mandel Center for Hypertension Research, Duke University Medical Center, Durham, North Carolina, USA
    • Cardiology Division, Department of Medicine, Duke University Medical Center, Durham, North Carolina, USA
    • ,
  • Zhiping Zhang, MD, PhD

      Affiliations

    • Mandel Center for Hypertension Research, Duke University Medical Center, Durham, North Carolina, USA
    • Cardiology Division, Department of Medicine, Duke University Medical Center, Durham, North Carolina, USA
    • ,
  • Richard E. Pratt, PhD

      Affiliations

    • Mandel Center for Hypertension Research, Duke University Medical Center, Durham, North Carolina, USA
    • Cardiology Division, Department of Medicine, Duke University Medical Center, Durham, North Carolina, USA
    • ,
  • Victor J. Dzau, MD

      Affiliations

    • Mandel Center for Hypertension Research, Duke University Medical Center, Durham, North Carolina, USA
    • Cardiology Division, Department of Medicine, Duke University Medical Center, Durham, North Carolina, USA
    • Corresponding Author InformationCorresponding author: Victor J. Dzau, MD, Office of the Chancellor, Duke University Medical Center, Durham, North Carolina 27710. Tel: 919-684-2255; fax: 919-681-7020.

Received 5 January 2007 ,Accepted 19 February 2007.

References 

  1. Owen RA, Molon-Noblot S, Hubert MF, Kindt MV, Keenan KP, Eydelloth RS. The morphology of juxtaglomerular cell hyperplasia and hypertrophy in normotensive rats and monkeys given an angiotensin II receptor antagonist. Toxicol Pathol. 1995;23:606–619
  2. Tamura K, Chen YE, Horiuchi M, et al. LXRα functions as a cAMP-responsive transcriptional regulator of gene expression. Proc Natl Acad Sci U S A. 2000;97:8513–8518
  3. Anderson LM, Choe SE, Yukhananov RY, et al. Identification of a novel set of genes regulated by a unique liver X receptor-alpha-mediated transcription mechanism. J Biol Chem. 2003;278:15252–15260
  4. Morello F, de Boer RA, Steffensen KR, et al. Liver X receptors alpha and beta regulate renin expression in vivo. J Clin Invest. 2005;115:1913–1922
  5. Bader M, Ganten D. Regulation of renin: new evidence from cultured cells and genetically modified mice. J Mol Med. 2000;78:130–139
  6. Catanzaro DF, Sun J, Gilbert MT, et al. A Pit-1 binding site in the human renin gene promoter stimulates activity in pituitary, placental and juxtaglomerular cells. Kidney Int. 1994;46:1513–1515
  7. Germain S, Konoshita T, Philippe J, Corvol P, Pinet F. Transcriptional induction of the human renin gene by cyclic AMP requires cyclic AMP response element-binding protein (CREB) and a factor binding a pituitary-specific trans-acting factor (Pit-1) motif. Biochem J. 1996;316(Pt 1):107–113
  8. Horiuchi M, Nakamura N, Tang SS, Barrett G, Dzau VJ. Molecular mechanism of tissue-specific regulation of mouse renin gene expression by cAMP (Identification of an inhibitory protein that binds nuclear transcriptional factor). J Biol Chem. 1991;266:16247–16254
  9. Horiuchi M, Pratt RE, Nakamura N, Dzau VJ. Distinct nuclear proteins competing for an overlapping sequence of cyclic adenosine monophosphate and negative regulatory elements regulate tissue-specific mouse renin gene expression. J Clin Invest. 1993;92:1805–1811
  10. Nakamura N, Burt DW, Paul M, Dzau VJ. Negative control elements and cAMP responsive sequences in the tissue-specific expression of mouse renin genes. Proc Natl Acad Sci U S A. 1989;86:56–59
  11. Pan L, Black TA, Shi Q, et al. Critical roles of a cyclic AMP responsive element and an E-box in regulation of mouse renin gene expression. J Biol Chem. 2001;276:45530–45538
  12. Pan L, Gross KW. Transcriptional regulation of renin: an update. Hypertension. 2005;45:3–8
  13. Tamura K, Umemura S, Yamaguchi S, et al. Mechanism of cAMP regulation of renin gene transcription by proximal promoter. J Clin Invest. 1994;94:1959–1967
  14. Mayr B, Montminy M. Transcriptional regulation by the phosphorylation-dependent factor CREB. Nat Rev Mol Cell Biol. 2001;2:599–609
  15. Cooke NE, Baxter JD. Structural analysis of the prolactin gene suggests a separate origin for its 5′ end. Nature. 1982;297:603–606
  16. Nagamine Y, Sudol M, Reich E. Hormonal regulation of plasminogen activator mRNA production in porcine kidney cells. Cell. 1983;32:1181–1190
  17. Shinomiya T, Scherer G, Schmid W, Zentgraf H, Schutz G. Isolation and characterization of the rat tyrosine aminotransferase gene. Proc Natl Acad Sci U S A. 1984;81:1346–1350
  18. Barrett G, Horiuchi M, Paul M, Pratt RE, Nakamura N, Dzau VJ. Identification of a negative regulatory element involved in tissue-specific expression of mouse renin genes. Proc Natl Acad Sci U S A. 1992;89:885–889
  19. Tomita S, Tomita N, Yamada T, et al. Transcription factor decoy to study the molecular mechanism of negative regulation of renin gene expression in the liver in vivo. Circ Res. 1999;84:1059–1066
  20. Yamada T, Horiuchi M, Morishita R, Zhang L, Pratt RE, Dzau VJ. In vivo identification of a negative regulatory element in the mouse renin gene using direct gene transfer. J Clin Invest. 1995;96:1230–1237
  21. Jones CA, Hurley MI, Black TA, et al. Expression of a renin/GFP transgene in mouse embryonic, extra-embryonic, and adult tissues. Physiol Genomics. 2000;4:75–81
  22. Arnold I, Watt FM. c-Myc activation in transgenic mouse epidermis results in mobilization of stem cells and differentiation of their progeny. Curr Biol. 2001;11:558–568
  23. Bendit I, Rich MA, Moldwin R, Waber P, Steinberg BM, Nisen PD. N-myc oncogene expression in porcine renal development and oncogenesis. Pediatr Res. 1991;29:268–271
  24. Douglas NC, Jacobs H, Bothwell AL, Hayday AC. Defining the specific physiological requirements for c-Myc in T cell development. Nat Immunol. 2001;2:307–315
  25. Downs KM, Martin GR, Bishop JM. Contrasting patterns of myc and N-myc expression during gastrulation of the mouse embryo. Genes Dev. 1989;3:860–869
  26. Gandarillas A, Watt FM. Changes in expression of members of the fos and jun families and myc network during terminal differentiation of human keratinocytes. Oncogene. 1995;11:1403–1407
  27. Gandarillas A, Watt FM. c-Myc promotes differentiation of human epidermal stem cells. Genes Dev. 1997;11:2869–2882
  28. Henriksson M, Luscher B. Proteins of the c-Myc network: essential regulators of cell growth and differentiation. Adv Cancer Res. 1996;68:109–182
  29. Malynn BA, de Alboran IM, O’Hagan RC, et al. N-myc can functionally replace c-Myc in murine development, cellular growth, and differentiation. Genes Dev. 2000;14:1390–1399
  30. Romand R, Hirning-Folz U, Ehret G. N-myc expression in the embryonic cochlea of the mouse. Hear Res. 1994;72:53–58
  31. St. Arnaud R, Nepveu A, Marcu KB, McBurney MW. Two transient increases in c-Myc gene expression during neuroectodermal differentiation of mouse embryonal carcinoma cells. Oncogene. 1988;3:553–559
  32. Waikel RL, Kawachi Y, Waikel PA, Wang XJ, Roop DR. Deregulated expression of c-Myc depletes epidermal stem cells. Nat Genet. 2001;28:165–168
  33. Sigmund CD, Okuyama K, Ingelfinger J, et al. Isolation and characterization of renin-expressing cell lines from transgenic mice containing a renin-promoter viral oncogene fusion construct. J Biol Chem. 1990;265:19916–19922
  34. Zhang Z, Anderson LM, Morello F, et al. Nuclear hormone receptor LXRα mediates renin and early response gene expressions, and proliferation of juxtaglomerular As4.1 cells: A unifying molecular mechanism for JG cell hyperplasia. Hypertension. 2006;48:e74;(Abstract: Poster presented at 60th Annual Fall Conference and Scientific Sessions of the Council for High Blood Pressure Research in association with the Council on the Kidney in Cardiovascular Disease, American Heart Association. October 4–7, 2006. San Antonio, Texas, USA)
  35. Sequeira Lopez ML, Pentz ES, Nomasa T, Smithies O, Gomez RA. Renin cells are precursors for multiple cell types that switch to the renin phenotype when homeostasis is threatened. Dev Cell. 2004;6:719–728
  36. Sequeira Lopez ML, Pentz ES, Robert B, Abrahamson DR, Gomez RA. Embryonic origin and lineage of juxtaglomerular cells. Am J Physiol Renal Physiol. 2001;281:F345–F356
  37. Matsushita K, Wu Y, Okamoto Y, Pratt RE, Dzau VJ. Local renin angiotensin expression regulates human mesenchymal stem cell differentiation to adipocytes. Hypertension. 2006;48:1095–1102
  38. Matsushita K, Morello F, Pratt RE, Dzau VJ. Hydroxycholesterol or cyclic AMP upregulates the expression of renin in human mesenchymal stem cells (Abstract: Poster presented at Scientific Sessions 2006, American Heart Association. November 12–15, 2006. Chicago, Illinois, USA). Circulation. 2006;114(Suppl II):II–94
  39. Al-Awqati Q, Oliver JA. Stem cells in the kidney. Kidney Int. 2002;61:387–395
  40. Anglani F, Forino M, Del Prete D, Tosetto E, Torregrossa R, D’Angelo A. In search of adult renal stem cells. J Cell Mol Med. 2004;8:474–487
  41. Morigi M, Imberti B, Zoja C, et al. Mesenchymal stem cells are renotropic, helping to repair the kidney and improve function in acute renal failure. J Am Soc Nephrol. 2004;15:1794–1804
  42. Oliver JA, Maarouf O, Cheema FH, Martens TP, Al-Awqati Q. The renal papilla is a niche for adult kidney stem cells. J Clin Invest. 2004;114:795–804
  43. Yokoo T, Ohashi T, Shen JS, et al. Human mesenchymal stem cells in rodent whole-embryo culture are reprogrammed to contribute to kidney tissues. Proc Natl Acad Sci U S A. 2005;102:3296–3300

 This study was supported by the National Heart, Lung, and Blood Institute (Grant nos. R01 HL35610, HL58516, HL72010, and HL73219 [VJD]) and the Edna Mandel Foundation (VJD).Conflict of interest: none.

PII: S1933-1711(07)00059-9

doi: 10.1016/j.jash.2007.02.004

Journal of the American Society of Hypertension
Volume 1, Issue 3 , Pages 164-168 , May 2007

Article Tools

* Image Usage & Resolution